We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INM market cap is 2.49M. The company's latest EPS is USD -0.9510 and P/E is -0.30.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.03M | 2.31M | 902k | 1.24M | 1.17M |
| Operating Income | -2.73M | -517k | -2.63M | -1.53M | -2.06M |
| Net Income | -2M | -339k | -2.54M | -1.48M | -1.72M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 1.09M | 4.14M |
| Operating Income | -13.64M | -9.15M | -9.94M | -17.27M | -8.38M |
| Net Income | -13.26M | -8.94M | -10.2M | -18.6M | -7.95M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.73M | 14.11M | 10.92M | 15.26M | 13.36M |
| Total Liabilities | 2.34M | 2.02M | 1.34M | 2.48M | 2.25M |
| Total Equity | 12.39M | 12.09M | 9.58M | 12.77M | 11.11M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.79M | 7.8M | 9.78M | 12.79M | 14.11M |
| Total Liabilities | 1.56M | 1.93M | 2.41M | 3.71M | 2.02M |
| Total Equity | 18.23M | 5.88M | 7.38M | 9.08M | 12.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.63M | -7.28M | -2.17M | -4.02M | -5.96M |
| Investing | -628k | -662k | N/A | -9k | -9k |
| Financing | 10.68M | 10.68M | N/A | 4.65M | 4.65M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.77M | -7.38M | -9.79M | -15.58M | -7.28M |
| Investing | -2.76M | 3.79M | -2k | -673k | -662k |
| Financing | 273k | -31k | 10.86M | 15.07M | 10.68M |
| Market Cap | 2.49M |
| Price to Earnings Ratio | -0.30 |
| Price to Sales Ratio | 0.59 |
| Price to Cash Ratio | 0.27 |
| Price to Book Ratio | 0.2 |
| Dividend Yield | - |
| Shares Outstanding | 8.36M |
| Average Volume (1 week) | 3.98M |
| Average Volume (1 Month) | 1.4M |
| 52 Week Change | -73.91% |
| 52 Week High | 2.08 |
| 52 Week Low | 0.2122 |
| Spread (Intraday) | 0.01 (2.18%) |
| Company Name | InMed Pharmaceuticals Inc |
| Address |
340 - 200 granville street vancouver, british columbia V6C 1S4 |
| Website | https://www.inmedpharma.com |
| Industry | security systems service (7382) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
